Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes.

David, Ebenezer

Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomes. [electronic resource] - Blood Dec 2010 - 5285-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2010-03-272393 doi


Apoptosis--drug effects
Autophagy
Boronic Acids--pharmacology
Bortezomib
Cell Line, Tumor
Drug Synergism
Drug Therapy, Combination
Humans
Multiple Myeloma--drug therapy
Proteasome Inhibitors
Pyrazines--pharmacology
Quinolones
Ubiquitination--drug effects